newsfilter
← Latest News
GlobeNewswire·

Nabriva Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

DUBLIN, Ireland and FORT WASHINGTON, Pa., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ:NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infec